Starting from the end of the 1970s, intraoperative ultrasound was introduced and developed to stage liver disease and guide the surgical interventions in patients with hepatocellular carcinoma. Without intraoperative ultrasound, it would probably be impossible to correctly define the hepatic segments as well as the limits of a tumor, also because of the existing wide variations in the anatomy. More importantly, intraoperative ultrasound allows for three-dimensional reconstruction of the relationships between the tumor, hepatic veins, and Glissonian pedicles. Such reconstruction is essential for planning the surgical strategy, which should be individualized in each patient with the aim to spare functional liver parenchyma. This work focuses on the role of intraoperative ultrasound to stage liver disease and to plan surgical resection, describing the most recent technical achievements.

Keywords:
Intraoperative ultrasound, Hepatocellular carcinoma, Tumor limits
1.
Adam R, Majno P, Castaing D, et al: Treatment of irresectable liver tumors by percutaneous cryosurgery. Br J Surg 1998;85:1493–1494.
2.
Livraghi T, Giorgio A, Marin G, et al: Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 1995;197:101–108.
3.
Makuuchi M, Yamazaki S, Hasegawa H, et al: Ultrasonically guided liver surgery. Jpn J Ultrason Med 1980;7:45–49.
4.
Solbiati L, Livraghi T, Goldberg SN, et al: Percutaneous radiofrequency ablation of hepatic metastases from colorectal cancer in 117 patients. Radiology 2001;221:159–166.
5.
Makuuchi M, Torzilli G, Machi J: History of intraoperative ultrasonography. Ultrasound Med Biol 1998;24:1229–1242.
6.
Teh SH, Christein J, Donohue J, et al: Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of End-stage Liver Disease (MELD) score predicts perioperative mortality. J Gastrointest Surg 2005;9:1207–1215.
7.
Schroeder RA, Marroquin CE, Bute BP, et al: Predictive indices of morbidity and mortality after liver resection. Ann Surg 2006;243:373–379.
8.
Donadon M, Torzilli G: Intraoperative ultrasound of the liver. AJR Am J Roentgenol 2012;198:W398.
9.
Hata S, Imamura H, Aoki T, et al: Value of visual inspection, bimanual palpation, and intraoperative ultrasonography during hepatic resection for liver metastases of colorectal carcinoma. World J Surg 2011;35:2779–2787.
10.
Ayuso C, Rimola J, García-Criado A: Imaging of HCC. Abdom Imaging 2012;37:215–230.
11.
Kim YK, Kwak HS, Kim CS, et al: Hepatocellular carcinoma in patients with chronic liver disease: comparison of SPIO-enhanced MR imaging and 16-detector row CT. Radiology 2006;238:531–541.
12.
Sun HY, Lee JM, Shin CH, et al: Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (≤2 cm in diameter) from arterial enhancing pseudolesions. Special emphasis on hepatobiliary phase imaging. Invest Radiol 2010;45:96–103.
13.
Vauthey JN, Dixon E, Abdalla EK, et al; American Hepato-Pancreato-Biliary Association; Society of Surgical Oncology; Society for Surgery of the Alimentary Tract: Pretreatment assessment of hepatocellular carcinoma: expert consensus statement. HPB (Oxford) 2010;12:289–299.
14.
Hammerstingl R, Huppertz A, Breuer J, et al; European EOB-study group: Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions. Eur Radiol 2008;18:457–467.
15.
Takigawa Y, Sugawara Y, Yamamoto J, et al: New lesions detected by intraoperative ultrasound during liver resection for hepatocellular carcinoma. Ultrasound Med Biol 2001;27:151–156.
16.
Matsuda Y, Yabuuchi I: Hepatic tumors: US contrast enhancement with CO2 microbubbles. Radiology 1986;161:701–705.
17.
Kudo M, Tomita S, Tochio H, et al: Small hepatocellular carcinoma: diagnosis with US angiography with intraarterial CO2 microbubbles. Radiology 1992;182:155–160.
18.
Blomley MJ, Albrecht T, Cosgrove DO, et al: Improved imaging of liver metastases with stimulated acoustic emission in the late phase of enhancement with the US contrast agent SH U 508A: early experience. Radiology 1999;210:409–416.
19.
Heckemann RA, Cosgrove DO, Blomley MJ, et al: Liver lesions: intermittent second-harmonic gray-scale US can increase conspicuity with microbubble contrast material – early experience. Radiology 2000;216:592–596.
20.
Leen E, Angerson WJ, Yarmenitis S, et al: Multi-centre clinical study evaluating the efficacy of SonoVue (BR1), a new ultrasound contrast agent in Doppler investigation of focal hepatic lesions. Eur J Radio 2002;41:200–206.
21.
Quaia E, Calliada F, Bertolotto M, et al: Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology 2004;232:420–430.
22.
Piscaglia F, Lencioni R, Sagrini E, et al: Characterization of focal liver lesions with contrast-enhanced ultrasound. Ultrasound Med Biol 2010;36:531–550.
23.
Arita J, Takahashi M, Hata S, et al: Usefulness of contrast-enhanced intraoperative ultrasound using sonazoid in patients with hepatocellular carcinoma. Ann Surg 2011;254:992–999.
24.
Torzilli G: Contrast-enhanced ultrasonography during liver surgery. Br J Surg 2004;91:1165–1167.
25.
Roncalli M, Roz E, Coggi G, et al: The vascular profile of regenerative and dysplastic nodules of the cirrhotic liver: implications for diagnosis and classification. Hepatology 1999;30:1174–1178.
26.
Torzilli G, Palmisano A, Del Fabbro D, et al: Contrast-enhanced intraoperative ultrasonography during surgery for hepatocellular carcinoma in liver cirrhosis: is it useful or useless? A prospective cohort study of our experience. Ann Surg Oncol 2007;14:1347–1355.
27.
Torzilli G, Montorsi M, Donadon M, et al: ‘Radical but conservative’ is the main goal for ultrasonography-guided liver resection: prospective validation of this approach. J Am Coll Surg 2005;201:517–528.
28.
Torzilli G, Makuuchi M: Ultrasound-guided finger compression in liver subsegmentectomy for hepatocellular carcinoma. Surg Endosc 2004;18:136–139.
29.
Torzilli G, Procopio F, Cimino M, et al: Anatomical segmental and subsegmental resection of the liver for hepatocellular carcinoma: a new approach by means of ultrasound-guided vessel compression. Ann Surg 2010;251:229–235.
30.
Torzilli G, Procopio F, Palmisano A, et al: New technique for defining the right anterior section intraoperatively using ultrasound-guided finger counter-compression. J Am Coll Surg 2009;209:e8–e11.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.